These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 6350816)

  • 1. Hemodynamic factors in the genesis of diabetic microangiopathy.
    Parving HH; Viberti GC; Keen H; Christiansen JS; Lassen NA
    Metabolism; 1983 Sep; 32(9):943-9. PubMed ID: 6350816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased capillary permeability in diabetes mellitus and its relationship to microvascular angiopathy.
    Viberti GC
    Am J Med; 1983 Nov; 75(5B):81-4. PubMed ID: 6673594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathogenesis of diabetic microangiopathy. The hemodynamic view.
    Zatz R; Brenner BM
    Am J Med; 1986 Mar; 80(3):443-53. PubMed ID: 3513561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma protein changes, blood viscosity, and diabetic microangiopathy.
    McMillan DE
    Diabetes; 1976; 25(2 SUPPL):858-64. PubMed ID: 971790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pathogenesis of diabetic microangiopathy].
    Caimi G; Lo Presti R
    Minerva Endocrinol; 1993 Jun; 18(2):49-68. PubMed ID: 8289751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of hemodynamic and vascular albumin filtration changes in diabetic rats by aldose reductase inhibitors.
    Tilton RG; Chang K; Pugliese G; Eades DM; Province MA; Sherman WR; Kilo C; Williamson JR
    Diabetes; 1989 Oct; 38(10):1258-70. PubMed ID: 2507378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Changes in microcirculation and selected laboratory parameters in the early stages of diabetic microangiopathy].
    Skrha J; Prázný M; Kvasnicka J; Kalvodová B
    Cas Lek Cesk; 2001 Jun; 140(12):370-4. PubMed ID: 11503186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacoclinical study of the action of vinburnin versus placebo: study of the hemodynamic, microcirculatory and rheological effects in angiopathy of the lower limbs in diabetes mellitus.
    Le Devehat C; Vimeux M
    Int Angiol; 1989; 8(1):57-61. PubMed ID: 2671200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The mechanisms responsible for the development of diabetic nephroangiopathy].
    Saltykov BB
    Arkh Patol; 2008; 70(5):38-42. PubMed ID: 19137784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microcirculation and diabetes.
    Tooke JE
    Br Med Bull; 1989 Jan; 45(1):206-23. PubMed ID: 2676070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal microvascular injury in diabetes: RAGE and redox signaling.
    Coughlan MT; Cooper ME; Forbes JM
    Antioxid Redox Signal; 2007 Mar; 9(3):331-42. PubMed ID: 17184182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered skeletal muscle microvascular hemodynamics after one week of streptozotocin-induced diabetes.
    Hill MA; Meininger GA; Granger HJ
    Microcirc Endothelium Lymphatics; 1985; 2(6):687-704. PubMed ID: 3837177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diabetic angiopathy and neuropathy. A review with special reference to circulation in the extremities, the effect of hypophysectomy on capillary resistance and capillary permeability, functional abnormalities in early diabetes.
    Christensen NJ
    Acta Med Scand Suppl; 1972; 541():3-60. PubMed ID: 4571960
    [No Abstract]   [Full Text] [Related]  

  • 14. Diabetic microangiopathy: Pathogenetic insights and novel therapeutic approaches.
    Madonna R; Balistreri CR; Geng YJ; De Caterina R
    Vascul Pharmacol; 2017 Mar; 90():1-7. PubMed ID: 28137665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advanced products of nonenzymatic glycosylation and the pathogenesis of diabetic vascular disease.
    Brownlee M; Cerami A; Vlassara H
    Diabetes Metab Rev; 1988 Aug; 4(5):437-51. PubMed ID: 2850143
    [No Abstract]   [Full Text] [Related]  

  • 16. Manifestations of cutaneous diabetic microangiopathy.
    Ngo BT; Hayes KD; DiMiao DJ; Srinivasan SK; Huerter CJ; Rendell MS
    Am J Clin Dermatol; 2005; 6(4):225-37. PubMed ID: 16060710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Growth hormone, insulin-like growth factor and insulin-like growth factor binding protein in young type I diabetes patients with the onset of diabetic angiopathy].
    Peczyńska J; Urban M; Głowińska B; Urban B
    Pol Merkur Lekarski; 2003 Apr; 14(82):336-9. PubMed ID: 12868196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microvascular function in human diabetes. A physiological perspective.
    Tooke JE
    Diabetes; 1995 Jul; 44(7):721-6. PubMed ID: 7789639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The diabetic arteriole: the impact of diabetic microangiopathy on microcirculatory control.
    Kastrup J
    Dan Med Bull; 1988 Aug; 35(4):334-45. PubMed ID: 3048921
    [No Abstract]   [Full Text] [Related]  

  • 20. [State of the microcirculatory component of hemostasis and microhemodynamics in patients with diabetic angiopathies].
    Petrova TR; Pavlishchuk SA; Vil'chinskaia MN
    Ter Arkh; 1984; 56(8):129-32. PubMed ID: 6495194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.